{"name":"Michelle Zeller","slug":"michelle-zeller","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Sex-mismatched red blood cell transfusions","genericName":"Sex-mismatched red blood cell transfusions","slug":"sex-mismatched-red-blood-cell-transfusions","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Sex-mismatched red blood cell transfusions","genericName":"Sex-mismatched red blood cell transfusions","slug":"sex-mismatched-red-blood-cell-transfusions","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNWVB0NlJBQzVqVEZjRWNFWkZIcktDZUJiM1pSV1kwTkkzVm9Ua1FlcXprOTlVOVJST3hfUFhMNEF4MFVCOTByRnlYRUFUZnRVa09KNktfZHR6OVQ3S3B1Qm5RU0xZS3lzWTJyWFRpM3NKV28yWFpRNWRnWkpzLWtMMFh4SG9IWFpucUhKUHlYSEFodHFqSmVWakY2SQ?oc=5","date":"2022-11-23","type":"pipeline","source":"Crain's Detroit","summary":"Plaintiff in Shefit lawsuit alleges culture at odds with company's inclusive branding - Crain's Detroit","headline":"Plaintiff in Shefit lawsuit alleges culture at odds with company's inclusive branding - Crain's Detroit","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}